Skip to main content

Table 1 Prediction table with the hazard ratios, confidence intervals and p values for the patient populations (n = 36)

From: Mitosis in circulating tumor cells stratifies highly aggressive breast carcinomas

Variable

Hazard ratio

95 % CI

P value

1 mitotic CTC vs 0 mitotic CTC

11.1

3.1-39.7

<0.001

≥5 CTC vs <5 CTC

5.2

1.6-16.5

0.005

1 mitotic CTC or ≥5 CTCs vs 0 mitotic CTCs and <5 CTCs

8.0

1.8-35.4

0.006

ER/PR-positive vs ER/PR-negative

1.3

0.5-3.7

0.174

HER2-positive vs HER2-negative

1.8

0.6-5.7

0.289

Hormone-positive vs hormone-negative (tn)

4.0

1.4-11.2

0.009

  1. CTC circulating tumor cell, ER estrogen receptor, PR progesterone receptor, HER2 human epidermal growth factor receptor-2, Tn triple negative